<DOC>
	<DOCNO>NCT01451606</DOCNO>
	<brief_summary>This study examine effectiveness duloxetine treatment chronic pelvic pain woman . Duloxetine FDA approve treatment pain condition , include fibromyalgia diabetic neuropathy .</brief_summary>
	<brief_title>Duloxetine Treatment Chronic Pelvic Pain</brief_title>
	<detailed_description>Chronic pelvic pain woman cause various pathology , endometriosis , fibroid , adhesion . Surgical treatment pathology often relieve pain , significant number woman continue pain , even visibly successful surgery . One model explore study case chronic pelvic pain , central nervous system change process pain-related signal , require therapy direct CNS effectively treat pain . This model support study chronic pain condition , fibromyalgia migraine . This study seek determine whether analgesic effectiveness duloxetine relate pain state individual .</detailed_description>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>premenopausal adult woman , age 1850 Have chronic pelvic pain , define American College Obstetrics Gynecology Able read speak English Chronic Pelvic Pain present low back vulva , present menstruation vaginal intercourse Selfreport documentation CPP sit attribute prior physician IBS , IC/PBS , urinary tract infection , urinary stone , inflammatory bowel disease ( ulcerative colitis Crohn 's disease ) , cancer shingle . Currently pregnant lactate A primary psychiatric diagnosis major depression history suicide attempt assess medical history . Also , would consider Major Depressive Disorder ( MDD ) basis DSMIV criterion exclude , well select `` 3 '' `` 4 '' item # 9 BDI ( suicidal ideation ) . A history bipolar disorder A history seizure disorder Orthostatic Hypertension Exclusions base effect duloxetine : 1 . Known hypersensitivity duloxetine inactive ingredient Cymbalta ; 2 . Treatment monoamine oxidase inhibitor ( MAOI ) within 14 day randomization , potential need use MAOI study within 5 day discontinuation drug ; 3 . Treatment cytochrome P450 enzyme inhibitor ; 4 . Uncontrolled narrowangle glaucoma ; 5 . Concurrent use thioridazine 6 . Renal Impairment ( serum creatinine 1.5 great ) 7 . History jaundice hepatomegaly 8 . Hepatic Insufficiency ( elevate AST , ALT , bilirubin , Alkaline Phosphatase ) , test screening period , first week study medication , midpoint study . Participants take SSRIs , SSNRIs , MAOIs , tricyclic within 14 day randomization exclude . Participants currently meet DSMIV diagnostic criterion Alcohol Abuse Dependence Weight exceed 285 pound Hyponatremia , determine blood test result</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Chronic Pelvic Pain</keyword>
	<keyword>CPP</keyword>
	<keyword>Pelvic Pain</keyword>
</DOC>